Markers of liver damage such as alanine amino transferase, aspartate amino transferase, gamma-glutamyl transpeptidase (P < 0.001), and alkaline phosphatase (0.027) were all elevated in NASH as compared to healthy controls. Here, GGTLC1 is linked to metabolic dysfunction-associated steatohepatitis.